Sporanox Indications/Uses

SPORANOX capsules are indicated for the following conditions: Gynecological indications: Treatment of vulvovaginal candidosis.
Dermatological/mucosal/ophthalmological indications: Treatment of dermatomycosis, including highly keratinized regions as in plantar tinea pedis and palmar tinea manus;
Treatment of pityriasis versicolor;
Treatment of oral candidosis.
Treatment of onychomycosis, caused by dermatophytes and/or yeasts.
Systemic mycoses, only in the following fungal infections: Treatment of systemic aspergillosis and candidosis;
Cryptococcosis (including cryptococcal meningitis): Treatment of immunocompromised patients with cryptococcosis and in all patients with cryptococcosis of the central nervous system, only when first line treatment is considered inappropriate or has proven ineffective;
For maintenance therapy of cryptococcal meningitis in AIDS patients, only when first line treatment is considered inappropriate or has proven ineffective.
Treatment of histoplasmosis;
Histoplasmosis, maintenance therapy only in AIDS patients;
Treatment of blastomycosis;
Treatment of sporotrichosis, including lymphocutaneous/cutaneous and extracutaneous;
Treatment of paracoccidioidomycosis;
Treatment of chromomycosis.